AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2017
Apr 4, 2017
35119_dirs_2017-04-04_e2daad7a-5be5-4f6a-83db-d1f0b53b5b14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2017-03-31
Reporting Person: Krumeich Karen R (SVP and CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | Option (Right to Buy) | $2.67 | A | 20000 | Acquired | 2027-03-30 | Common Stock (20000) | Direct |
Footnotes
F1: The stock option vested immediately as to 5,000 shares and vests as to the remainder at a rate of 1,250 of the shares on each three (3) month anniversary of March 31, 2017.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3